USANA Health Expects Q2 Sales $147M vs. 134.9M Est on EPS of at Least $0.85 vs. $0.71 Est

USANA Health Sciences, Inc. USNA today reported that preliminary net sales for its fiscal second quarter ending July 2, 2011 are expected to exceed $147.0 million and earnings per share for the quarter are expected to be at or above $0.85. Earnings per share for the period will benefit by approximately $0.06 due to the recapture of unvested equity compensation expense related to the departure of certain executives from the Company. The Company plans to release final results for the second quarter, as well as update its annual financial guidance, after market close on July 26th. The Company will host a conference call to discuss its progress on Wednesday morning, July 27th. Chief Executive Officer Dave Wentz said, “Our senior management transition announced on May 10, 2011 was smoothly and successfully implemented during the quarter, reflecting the strong leadership qualities and dedication of our management team, as well as the depth of our organization. We are grateful for the significant amount of time and input our Associate leaders provided our management team during this transition. After considering input from our Associate leaders, Deborah Woo, our new President of Asia Pacific, recommended a revised approach to our integration strategy for BabyCare in China. We implemented our new strategy mid-quarter and believe this revised approach contributed to our results for the quarter.”